CLPT ClearPoint Neuro, Inc.

NASDAQ
$9.64

ClearPoint Neuro, Inc. (CLPT) is confirmed to report earnings on October 28, 2026, after the market close. The consensus earnings estimate is a loss of $0.27 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -35.4% since its last earnings release on August 3, 2026.

ClearPoint Neuro Missed Consensus Estimates
Monday, August 3, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 28
Wednesday · After Close
Earnings Whisper
-
vs ($0.27)
Rev est $12.5M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $13.35

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About ClearPoint Neuro, Inc.

ClearPoint Neuro’s mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.